Key result
Type 2 diabetes was an independent predictor of lowered peak oxygen uptake in chronic heart failure patients with both non-reduced and reduced left ventricular ejection fraction.
Why the study?
Although type 2 diabetes mellitus is a frequent comorbidity in chronic heart failure, its effects on exercise capacity remain fully unknown.
Does the presence of Type 2 Diabetes Mellitus reduce peak oxygen uptake in patients with chronic heart failure?
Cohort (n=275)
No
Does the presence of Type 2 Diabetes Mellitus reduce peak oxygen uptake in patients with chronic heart failure?
Type 2 diabetes is an independent predictor of reduced peak aerobic capacity in patients with chronic heart failure, regardless of whether their left ventricular ejection fraction is reduced or non-reduced.
Answers are grounded in this paper and cite their sources.
Supports diabetes evaluation during HF CPET; hypothesis-generating, requiring interventional trials before practice change.
Background Although type 2 diabetes mellitus (T2DM) is one of the most frequent comorbidities in patients with chronic heart failure (CHF), the effects of T2DM on the exercise capacity of CHF patients are fully unknown. Here, we tested the hypothesis that the coexistence of T2DM lowers CHF patients’ peak aerobic capacity. Methods We retrospectively analyzed the cases of 275 Japanese CHF patients with non-reduced ejection fraction (left ventricular ejection fraction [LVEF] ≥ 40%) or reduced EF (LVEF < 40%) who underwent cardiopulmonary exercise testing. We divided them into diabetic and nondiabetic groups in each CHF cohort. Results The mean peak oxygen uptake (VO 2 ) value was 16.87 mL/kg/min in the non-reduced LVEF cohort and 15.52 mL/kg/min in the reduced LVEF cohort. The peak VO 2 was lower in the diabetics versus the nondiabetics in the non-reduced LVEF cohort with the mean difference (95% confidence interval [95% CI]) of − 0.93 (− 1.82 to − 0.04) mL/kg/min and in the reduced LVEF cohort with the mean difference of − 1.05 (− 1.96 to − 0.15) mL/kg/min, after adjustment for age-squared, gender, anemia, renal function, LVEF, and log B-type natriuretic peptide (BNP). The adjusted VO 2 at anaerobic threshold (AT), a submaximal aerobic capacity, was also decreased in the diabetic patients with both non-reduced and reduced LVEFs. Intriguingly, the diabetic patients had a lower adjusted peak O 2 pulse than the nondiabetic patients in the reduced LVEF cohort, but not in the non-reduced LVEF cohort. A multivariate analysis showed that the presence of T2DM was an independent predictor of lowered peak VO 2 in CHF patients with non-reduced LVEF and those with reduced LVEF. Conclusions T2DM was associated with lowered peak VO 2 in CHF patients with non-reduced or reduced LVEF. The presence of T2DM has a negative impact on CHF patients’ exercise capacity, and the degree of impact is partly dependent on their LV systolic function.
No takes yet. Share an insight, caveat, or question.
Abe et al. (2020) conducted a cohort in Chronic heart failure (n=275). Type 2 diabetes mellitus vs. Nondiabetic was evaluated on Peak oxygen uptake (VO2) in patients with non-reduced LVEF (≥ 40%) (Adjusted mean difference -0.93 mL/kg/min, 95% CI -1.82 to -0.04, p=0.04). Type 2 diabetes was an independent predictor of lowered peak oxygen uptake in chronic heart failure patients with both non-reduced and reduced left ventricular ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: